Global Lung Cancer Market Size, Status and Forecast 2019-2025
Table of Content
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Lung Cancer Revenue
- 1.4 Market by Type
- 1.4.1 Global Lung Cancer Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Surgery
- 1.4.3 Chemotherapy
- 1.4.4 Radiotherapy
- 1.4.5 Photodynamic Therapy
- 1.4.6 Laser Therapy
- 1.5 Market by Application
- 1.5.1 Global Lung Cancer Market Share by Application: 2020 VS 2026
- 1.5.2 Hospital & Clinics
- 1.5.3 Cancer Research Centers
- 1.5.4 Laboratories
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Global Lung Cancer Market Perspective (2015-2026)
- 2.2 Global Lung Cancer Growth Trends by Regions
- 2.2.1 Lung Cancer Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Lung Cancer Historic Market Share by Regions (2015-2020)
- 2.2.3 Lung Cancer Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Lung Cancer Market Growth Strategy
- 2.3.6 Primary Interviews with Key Lung Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Lung Cancer Players by Market Size
- 3.1.1 Global Top Lung Cancer Players by Revenue (2015-2020)
- 3.1.2 Global Lung Cancer Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Lung Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Lung Cancer Market Concentration Ratio
- 3.2.1 Global Lung Cancer Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Revenue in 2019
- 3.3 Lung Cancer Key Players Head office and Area Served
- 3.4 Key Players Lung Cancer Product Solution and Service
- 3.5 Date of Enter into Lung Cancer Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Lung Cancer Historic Market Size by Type (2015-2020)
- 4.2 Global Lung Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
- 5.1 Global Lung Cancer Market Size by Application (2015-2020)
- 5.2 Global Lung Cancer Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Lung Cancer Market Size (2015-2020)
- 6.2 Lung Cancer Key Players in North America (2019-2020)
- 6.3 North America Lung Cancer Market Size by Type (2015-2020)
- 6.4 North America Lung Cancer Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Lung Cancer Market Size (2015-2020)
- 7.2 Lung Cancer Key Players in Europe (2019-2020)
- 7.3 Europe Lung Cancer Market Size by Type (2015-2020)
- 7.4 Europe Lung Cancer Market Size by Application (2015-2020)
8 China
- 8.1 China Lung Cancer Market Size (2015-2020)
- 8.2 Lung Cancer Key Players in China (2019-2020)
- 8.3 China Lung Cancer Market Size by Type (2015-2020)
- 8.4 China Lung Cancer Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Lung Cancer Market Size (2015-2020)
- 9.2 Lung Cancer Key Players in Japan (2019-2020)
- 9.3 Japan Lung Cancer Market Size by Type (2015-2020)
- 9.4 Japan Lung Cancer Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Lung Cancer Market Size (2015-2020)
- 10.2 Lung Cancer Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Lung Cancer Market Size by Type (2015-2020)
- 10.4 Southeast Asia Lung Cancer Market Size by Application (2015-2020)
11 India
- 11.1 India Lung Cancer Market Size (2015-2020)
- 11.2 Lung Cancer Key Players in India (2019-2020)
- 11.3 India Lung Cancer Market Size by Type (2015-2020)
- 11.4 India Lung Cancer Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Lung Cancer Market Size (2015-2020)
- 12.2 Lung Cancer Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Lung Cancer Market Size by Type (2015-2020)
- 12.4 Central & South America Lung Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Roche
- 13.1.1 Roche Company Details
- 13.1.2 Roche Business Overview
- 13.1.3 Roche Lung Cancer Introduction
- 13.1.4 Roche Revenue in Lung Cancer Business (2015-2020))
- 13.1.5 Roche Recent Development
- 13.2 Novartis
- 13.2.1 Novartis Company Details
- 13.2.2 Novartis Business Overview
- 13.2.3 Novartis Lung Cancer Introduction
- 13.2.4 Novartis Revenue in Lung Cancer Business (2015-2020)
- 13.2.5 Novartis Recent Development
- 13.3 Pfizer
- 13.3.1 Pfizer Company Details
- 13.3.2 Pfizer Business Overview
- 13.3.3 Pfizer Lung Cancer Introduction
- 13.3.4 Pfizer Revenue in Lung Cancer Business (2015-2020)
- 13.3.5 Pfizer Recent Development
- 13.4 Merck
- 13.4.1 Merck Company Details
- 13.4.2 Merck Business Overview
- 13.4.3 Merck Lung Cancer Introduction
- 13.4.4 Merck Revenue in Lung Cancer Business (2015-2020)
- 13.4.5 Merck Recent Development
- 13.5 Bristol-Myers Squibb
- 13.5.1 Bristol-Myers Squibb Company Details
- 13.5.2 Bristol-Myers Squibb Business Overview
- 13.5.3 Bristol-Myers Squibb Lung Cancer Introduction
- 13.5.4 Bristol-Myers Squibb Revenue in Lung Cancer Business (2015-2020)
- 13.5.5 Bristol-Myers Squibb Recent Development
- 13.6 Eli Lilly And Company
- 13.6.1 Eli Lilly And Company Company Details
- 13.6.2 Eli Lilly And Company Business Overview
- 13.6.3 Eli Lilly And Company Lung Cancer Introduction
- 13.6.4 Eli Lilly And Company Revenue in Lung Cancer Business (2015-2020)
- 13.6.5 Eli Lilly And Company Recent Development
- 13.7 Sanof
- 13.7.1 Sanof Company Details
- 13.7.2 Sanof Business Overview
- 13.7.3 Sanof Lung Cancer Introduction
- 13.7.4 Sanof Revenue in Lung Cancer Business (2015-2020)
- 13.7.5 Sanof Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Description
Lung Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Novartis
Pfizer
Merck
Bristol-Myers Squibb
Eli Lilly And Company
Sanof
...
Market segment by Type, the product can be split into
Surgery
Chemotherapy
Radiotherapy
Photodynamic Therapy
Laser Therapy
Market segment by Application, split into
Hospital & Clinics
Cancer Research Centers
Laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America